How GPT-5 helped immunologist Derya Unutmaz solve a 3-year-old mystery

The advanced AI model analyzed complex datasets, identifying previously unrecognized patterns in T cell activation and differentiation. This breakthrough offers potential avenues for developing new treatments for cancer and autoimmune diseases. Unutmaz, affiliated with the Jackson Laboratory, utilized GPT-5 Pro's sophisticated analytical capabilities to sift through extensive genomic and proteomic data, a task that had eluded traditional computational methods.

The AI's ability to process and interpret high-dimensional biological information was crucial in pinpointing the specific molecular pathways involved in T cell responses. This advancement marks a significant step in leveraging artificial intelligence for complex biological research, potentially accelerating drug discovery and therapeutic development in immunology.